Keyphrases
Oligomeric
100%
Tauopathy
100%
Transgenic Animals
100%
Tau Oligomers
100%
Monoclonal Antibody
80%
Passive Immunity
80%
Aged Mice
60%
Aged Animals
60%
Overexpressing
40%
Alzheimer's Disease
40%
Antibody Clones
40%
Mouse Model
20%
Risk Factors
20%
Therapeutic Approaches
20%
Amyloid Plaques
20%
Serum IgE
20%
Disease Course
20%
Neurodegenerative Diseases
20%
Human Tissue
20%
Motor Activity
20%
Disease Progression
20%
Biochemical Assay
20%
Neurodegenerative
20%
Tau Aggregates
20%
Phosphorylated tau
20%
Neurofibrillary Tangles
20%
Multiple Injections
20%
Cognitive Function
20%
Brain Tissue
20%
Human tau
20%
Changes with Age
20%
Toxicity Profile
20%
Disease Pathology
20%
Novel Object Recognition
20%
Oligomeric tau
20%
Model Tissue
20%
Y-maze
20%
Immunohistochemical Assay
20%
Motor Phenotype
20%
P301L
20%
Tau Fibrils
20%
Rotarod Test
20%
Prion-like
20%
Tau Strains
20%
JNPL3
20%
Cognitive Phenotype
20%
HTau
20%
Aged Mouse Model
20%
Immunology and Microbiology
Immunotherapy
100%
Transgenic Animal
100%
Monoclonal Antibody
80%
Mouse Model
40%
Immunology
40%
Human Tissue
20%
Fibril
20%
Conformation
20%
Brain Tissue
20%
Cognition
20%
Rotarod Test
20%
Novel Object Recognition Test
20%
Prion Protein
20%
Neuroscience
Immunotherapy
100%
Oligomer
100%
Tauopathy
100%
Monoclonal Antibody
80%
In Vitro
20%
Neurodegenerative Disorder
20%
Cognitive Function
20%
Prion Protein
20%
Amyloid Protein
20%
Biochemistry, Genetics and Molecular Biology
Tau
100%
Transgenic Animal
100%
Monoclonal Antibody
26%
Mouse Model
13%
Neurofibrillary Tangle
6%
Conformation
6%
Cognition
6%
Motor Activity
6%
Novel Object Recognition Test
6%
Rotarod Test
6%
Amyloid Protein
6%
Prion Protein
6%